Navneet Majhail was named deputy physician-in-chief of blood cancers for the Sarah Cannon Transplant and Cellular Therapy Network (formerly the Sarah Cannon Blood Cancer Network).
In his role, Majhail will focus on the continued expansion of the Sarah Cannon Transplant and Cellular Therapy Network Centers of Excellence providing increased access for patients to cutting-edge cell and transplant therapies in the communities served by Sarah Cannon.
Majhail is director of the Cleveland Clinic’s Blood and Marrow Transplant Program, professor of medicine and vice chair for the Department of Hematology and Medical Oncology at the Cleveland Clinic Lerner College of Medicine.
He is a past-president of the American Society for Transplantation and Cellular Therapy and has been recognized as a fellow for his contributions to the field of transplantation and cellular therapy.
Majhail researches the prevention and management of early and late complications of hematopoietic cell transplantation and health policy issues such as healthcare disparities, quality of care, survivorship and economic issues related to transplantation and cellular therapy.
In addition to his work at Sarah Cannon, Majhail will be program medical director for the Sarah Cannon Transplant and Cellular Therapy Program at Centennial Medical Center.
Majhail will formally begin his position in late September 2021.
